发布求助
文献互助 智能选刊 最新文献

PharmacoEconomics & Outcomes News最新文献

筛选
英文 中文
UK's NICE does not recommend tucatinib for HER2-positive metastatic breast cancer 英国NICE不推荐图卡替尼治疗her2阳性转移性乳腺癌
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08195-6
{"title":"UK's NICE does not recommend tucatinib for HER2-positive metastatic breast cancer","authors":"","doi":"10.1007/s40274-021-08195-6","DOIUrl":"https://doi.org/10.1007/s40274-021-08195-6","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"58 14","pages":"37"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91448841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescription digital therapeutic, reSET-O, saves costs in US patients with opioid use disorder 处方数字治疗，reSET-O，为美国阿片类药物使用障碍患者节省成本
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08180-7
{"title":"Prescription digital therapeutic, reSET-O, saves costs in US patients with opioid use disorder","authors":"","doi":"10.1007/s40274-021-08180-7","DOIUrl":"https://doi.org/10.1007/s40274-021-08180-7","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"8 1","pages":"22 - 22"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86708579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast reduction surgery for symptomatic breast hypertrophy cost effective in Australia 乳房缩小手术治疗症状性乳房肥大在澳大利亚的成本效益
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08200-0
{"title":"Breast reduction surgery for symptomatic breast hypertrophy cost effective in Australia","authors":"","doi":"10.1007/s40274-021-08200-0","DOIUrl":"https://doi.org/10.1007/s40274-021-08200-0","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"5 1","pages":"5 - 5"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73099361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scottish Medicines Consortium accepts three new medicines and rejects one 苏格兰医药协会接受了三种新药，拒绝了一种
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08194-6
{"title":"Scottish Medicines Consortium accepts three new medicines and rejects one","authors":"","doi":"10.1007/s40274-021-08194-6","DOIUrl":"https://doi.org/10.1007/s40274-021-08194-6","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"82 1","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90100408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral semaglutide a cost-effective option for patients with uncontrolled T2DM 口服西马鲁肽对未控制的T2DM患者是一种经济有效的选择
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08178-8
{"title":"Oral semaglutide a cost-effective option for patients with uncontrolled T2DM","authors":"","doi":"10.1007/s40274-021-08178-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08178-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"33 1","pages":"20 - 20"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78698796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discontinuing antidepressants: no QALY gain, no cost savings in the short term in the UK 停止服用抗抑郁药:在英国，没有QALY收益，短期内没有成本节约
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08209-0
{"title":"Discontinuing antidepressants: no QALY gain, no cost savings in the short term in the UK","authors":"","doi":"10.1007/s40274-021-08209-0","DOIUrl":"https://doi.org/10.1007/s40274-021-08209-0","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"61 1","pages":"14 - 14"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76501955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empagliflozin less costly than other branded AHAs for T2DM patients with CVD in the USA 在美国，恩帕列净治疗伴有心血管疾病的2型糖尿病患者的成本低于其他品牌aha
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08169-9
{"title":"Empagliflozin less costly than other branded AHAs for T2DM patients with CVD in the USA","authors":"","doi":"10.1007/s40274-021-08169-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08169-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"1 1","pages":"11 - 11"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88755882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHO multi-dose vial policy for immunisation programme reduces wastage, saves costs in Egypt 世卫组织用于免疫规划的多剂量瓶政策在埃及减少浪费，节省成本
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08225-y
{"title":"WHO multi-dose vial policy for immunisation programme reduces wastage, saves costs in Egypt","authors":"","doi":"10.1007/s40274-021-08225-y","DOIUrl":"https://doi.org/10.1007/s40274-021-08225-y","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"8 1","pages":"30 - 30"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87104845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder 最新的NICE指南草案不推荐elusulfase用于罕见疾病
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08227-y
Meindert Boysen
{"title":"Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder","authors":"Meindert Boysen","doi":"10.1007/s40274-021-08227-y","DOIUrl":"https://doi.org/10.1007/s40274-021-08227-y","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"9 1","pages":"32 - 32"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87184196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Similar costs for mCRPC patients treated with abiraterone vs enzalutamide in Scotland 在苏格兰，阿比特龙与恩杂鲁胺治疗mCRPC患者的费用相似
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08217-z
{"title":"Similar costs for mCRPC patients treated with abiraterone vs enzalutamide in Scotland","authors":"","doi":"10.1007/s40274-021-08217-z","DOIUrl":"https://doi.org/10.1007/s40274-021-08217-z","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"46 1","pages":"22 - 22"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88994309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信